{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T01:21:20Z","timestamp":1769131280551,"version":"3.49.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":661,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01HL167956"],"award-info":[{"award-number":["R01HL167956"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["R01HL167956"],"award-info":[{"award-number":["R01HL167956"]}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,1]]},"DOI":"10.1513\/annalsats.202402-129ed","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T09:34:56Z","timestamp":1711964096000},"page":"543-545","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":0,"title":["Nonantibiotic Management of Nontuberculous Mycobacteria in Non\u2013Cystic Fibrosis Bronchiectasis: Natural or Nonsense?"],"prefix":"10.1093","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1605-1780","authenticated-orcid":false,"given":"Katherine B.","family":"Hisert","sequence":"first","affiliation":[{"name":"Department of Medicine, National Jewish Health, Denver, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8910-3449","authenticated-orcid":false,"given":"Jerry A.","family":"Nick","sequence":"additional","affiliation":[{"name":"Department of Medicine, National Jewish Health, Denver, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,4,1]]},"reference":[{"key":"2026012203145008300_bib1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciaa1125","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026012203145008300_bib2","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/sctm.20-0521","article-title":"Donor-defined mesenchymal stem cell antimicrobial potency against nontuberculous Mycobacterium","volume":"10","author":"Bonfield","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"2026012203145008300_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/cid\/ciac453","article-title":"Phage therapy of Mycobacterium infections: compassionate use of phages in 20 patients with drug-resistant mycobacterial disease","volume":"76","author":"Dedrick","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026012203145008300_bib4","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.cell.2022.04.024","article-title":"Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection","volume":"185","author":"Nick","year":"2022","journal-title":"Cell"},{"key":"2026012203145008300_bib5","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1128\/AAC.00331-15","article-title":"Gallium compounds exhibit potential as new therapeutic agents against Mycobacterium abscessus","volume":"59","author":"Abdalla","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012203145008300_bib6","doi-asserted-by":"crossref","first-page":"107069","DOI":"10.1016\/j.rmed.2022.107069","article-title":"Inhaled nitric oxide for adults with pulmonary non-tuberculous mycobacterial infection","volume":"206","author":"Flume","year":"2023","journal-title":"Respir Med"},{"key":"2026012203145008300_bib7","doi-asserted-by":"crossref","first-page":"1802143","DOI":"10.1183\/13993003.02143-2018","article-title":"Outcomes of hypertonic saline inhalation as a treatment modality in nontuberculous mycobacterial pulmonary disease","volume":"54","author":"Huiberts","year":"2019","journal-title":"Eur Respir J"},{"key":"2026012203145008300_bib8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ccm.2023.06.013","article-title":"Surgical resection in nontuberculous mycobacterial pulmonary disease","volume":"44","author":"Taylor","year":"2023","journal-title":"Clin Chest Med"},{"key":"2026012203145008300_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/MCP.0000000000000665","article-title":"Beyond antibiotics for pulmonary nontuberculous mycobacterial disease","volume":"26","author":"Waterer","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"2026012203145008300_bib10","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3390\/vaccines11081313","article-title":"Clinical and experimental determination of protection afforded by BCG vaccination against infection with non-tuberculous mycobacteria: a role in cystic fibrosis?","volume":"11","author":"Warner","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"2026012203145008300_bib11","article-title":"Eradication of nontuberculous mycobacteria in people with cystic fibrosis treated with elexacaftor\/tezacaftor\/ivacaftor: a multicenter cohort study","author":"Wiesel","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2026012203145008300_bib12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/nu11020343","article-title":"Assessment of vitamin status in patients with nontuberculous mycobacterial pulmonary disease: potential role of vitamin A as a risk factor","volume":"11","author":"Oh","year":"2019","journal-title":"Nutrients"},{"key":"2026012203145008300_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.coi.2018.06.001","article-title":"Acquired and genetic host susceptibility factors and microbial pathogenic factors that predispose to nontuberculous mycobacterial infections","volume":"54","author":"Honda","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"2026012203145008300_bib14","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.cmi.2022.03.004","article-title":"Mendelian susceptibility to mycobacterial diseases: state of the art","volume":"28","author":"Noma","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2026012203145008300_bib15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin Immunol"},{"key":"2026012203145008300_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12916-016-0606-6","article-title":"\u201cWhy me, why now?\u201d Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection","volume":"14","author":"Lake","year":"2016","journal-title":"BMC Med"},{"key":"2026012203145008300_bib17","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.jinf.2006.11.005","article-title":"The use of adjuvant granulocyte-macrophage colony-stimulating factor in HIV-related disseminated atypical mycobacterial infection","volume":"54","author":"de Silva","year":"2007","journal-title":"J Infect"},{"key":"2026012203145008300_bib18","doi-asserted-by":"crossref","first-page":"1702127","DOI":"10.1183\/13993003.02127-2017","article-title":"Inhaled granulocyte-macrophage colony-stimulating factor for Mycobacterium abscessus in cystic fibrosis","volume":"51","author":"Scott","year":"2018","journal-title":"Eur Respir J"},{"key":"2026012203145008300_bib19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1473-3099(10)70196-1","article-title":"Anticytokine autoantibodies in infectious diseases: pathogenesis and mechanisms","volume":"10","author":"Browne","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"2026012203145008300_bib20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/jac\/dkt451","article-title":"GM-CSF knockout mice for preclinical testing of agents with antimicrobial activity against Mycobacterium abscessus","volume":"69","author":"De Groote","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2026012203145008300_bib21","doi-asserted-by":"crossref","first-page":"e157865","DOI":"10.1172\/jci.insight.157865","article-title":"Tissue-localized immune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection","volume":"7","author":"Hayes","year":"2022","journal-title":"JCI Insight"},{"key":"2026012203145008300_bib22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1513\/AnnalsATS.202306-532OC","article-title":"OPTIMA: an open-label, noncomparative pilot trial of inhaled molgramostim in pulmonary nontuberculous mycobacterial infection","volume":"21","author":"Thomson","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203145008300_bib23","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1128\/AAC.00379-15","article-title":"Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis","volume":"59","author":"Kempker","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012203145008300_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12931-018-0862-4","article-title":"Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses","volume":"19","author":"Sheng","year":"2018","journal-title":"Respir Res"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/21\/4\/543\/66009574\/annalsats_21_4_543.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/21\/4\/543\/66009574\/annalsats_21_4_543.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:15:56Z","timestamp":1769069756000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/21\/4\/543\/8382026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,1]]},"published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202402-129ed","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,4,1]]},"assertion":[{"value":"2024-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}